Olfactory Impairment and the Risk of Major Adverse Cardiovascular Outcomes in Older Adults

Abstract

Background Olfactory impairment is common in older adults and may be associated with adverse cardiovascular health; however, empirical evidence is sparse. We examined olfaction in relation to the risk of coronary heart disease (CHD), stroke, and congestive heart failure (CHF). Methods and Results This study included 2537 older adults (aged 75.6±2.8 years) from the Health ABC (Health, Aging, and Body Composition) study with olfaction assessed by the 12‐item Brief Smell Identification Test in 1999 to 2000, defined as poor (score ≤8), moderate (9–10), or good (11–12). The outcomes were incident CHD, stroke, and CHF. During up to a 12‐year follow‐up, 353 incident CHD, 258 stroke, and 477 CHF events were identified. Olfaction was statistically significantly associated with incident CHF, but not with CHD or stroke. After adjusting for demographics, risk factors, and biomarkers of CHF, the cause‐specific hazard ratio (HR) of CHF was 1.32 (95% CI, 1.05–1.66) for moderate and 1.28 (95% CI, 1.01–1.64) for poor olfaction. These associations were robust in preplanned subgroup analyses by age, sex, race, and prevalent CHD/stroke. While the subgroup results were not statistically significantly different, the association of olfaction with CHF appeared to be evident among participants who reported very good to excellent health (HR, 1.47 [95% CI, 1.01–2.14] for moderate; and 1.76 [95% CI, 1.20–2.58] for poor olfaction), but not among those with fair to poor self‐reported health (HR, 1.04 [95% CI, 0.64–1.70] for moderate; and 0.92 [95% CI, 0.58–1.47] for poor olfaction). Conclusions In community‐dwelling older adults, a single olfaction test was associated with a long‐term risk for incident CHF, particularly among those reporting very good to excellent health.